» Articles » PMID: 24830455

Lactobacillus Rhamnosus GG and Bifidobacterium Longum Attenuate Lung Injury and Inflammatory Response in Experimental Sepsis

Overview
Journal PLoS One
Date 2014 May 17
PMID 24830455
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Probiotic use to prevent nosocomial gastrointestinal and potentially respiratory tract infections in critical care has shown great promise in recent clinical trials of adult and pediatric patients. Despite well-documented benefits of probiotic use in intestinal disorders, the potential for probiotic treatment to reduce lung injury following infection and shock has not been well explored.

Objective: Evaluate if Lactobacillus rhamnosus GG (LGG) or Bifidobacterium longum (BL) treatment in a weanling mouse model of cecal ligation and puncture (CLP) peritonitis will protect against lung injury.

Methods: 3 week-old FVB/N mice were orally gavaged with 200 µl of either LGG, BL or sterile water (vehicle) immediately prior to CLP. Mice were euthanized at 24 h. Lung injury was evaluated via histology and lung neutrophil infiltration was evaluated by myeloperoxidase (MPO) staining. mRNA levels of IL-6, TNF-α, MyD88, TLR-4, TLR-2, NFΚB (p50/p105) and Cox-2 in the lung analyzed via real-time PCR. TNF-α and IL-6 in lung was analyzed via ELISA.

Results: LGG and BL treatment significantly improved lung injury following experimental infection and sepsis and lung neutrophil infiltration was significantly lower than in untreated septic mice. Lung mRNA and protein levels of IL-6 and TNF-α and gene expression of Cox-2 were also significantly reduced in mice receiving LGG or BL treatment. Gene expression of TLR-2, MyD88 and NFΚB (p50/p105) was significantly increased in septic mice compared to shams and decreased in the lung of mice receiving LGG or BL while TLR-4 levels remained unchanged.

Conclusions: Treatment with LGG and BL can reduce lung injury following experimental infection and sepsis and is associated with reduced lung inflammatory cell infiltrate and decreased markers of lung inflammatory response. Probiotic therapy may be a promising intervention to improve clinical lung injury following systemic infection and sepsis.

Citing Articles

Keystone bacteria dynamics in chronic obstructive pulmonary disease (COPD): Towards differential diagnosis and probiotic candidates.

KavianFar A, Taherkhani H, Lanjanian H, Aminnezhad S, Ahmadi A, Azimzadeh S Heliyon. 2025; 11(4):e42719.

PMID: 40040961 PMC: 11876909. DOI: 10.1016/j.heliyon.2025.e42719.


The protective effect and immunomodulatory ability of orally administrated Lacticaseibacillus rhamnosus GG against Mycoplasma pneumoniae infection in BALB/c mice.

Long H, He G, He J, Du T, Feng P, Zhu C PLoS One. 2024; 19(10):e0312318.

PMID: 39453930 PMC: 11508164. DOI: 10.1371/journal.pone.0312318.


Host tracheal and intestinal microbiomes inhibit growth .

Tejeda-Garibay S, Zhao L, Hum N, Pimentel M, Diep A, Amiri B Microbiol Spectr. 2024; 12(7):e0297823.

PMID: 38832766 PMC: 11218535. DOI: 10.1128/spectrum.02978-23.


Fermented Milk Containing SNU50430 Modulates Immune Responses and Gut Microbiota in Antibiotic-Treated Mice.

Yoon S, Park S, Jung S, Lee C, Kim W, Choi I J Microbiol Biotechnol. 2024; 34(6):1299-1306.

PMID: 38755001 PMC: 11239404. DOI: 10.4014/jmb.2401.01012.


Host tracheal and intestinal microbiomes inhibit growth .

Tejeda-Garibay S, Zhao L, Hum N, Pimentel M, Diep A, Amiri B bioRxiv. 2023; .

PMID: 37961490 PMC: 10634762. DOI: 10.1101/2023.10.23.563655.


References
1.
Singleton K, Wischmeyer P . Glutamine's protection against sepsis and lung injury is dependent on heat shock protein 70 expression. Am J Physiol Regul Integr Comp Physiol. 2007; 292(5):R1839-45. DOI: 10.1152/ajpregu.00755.2006. View

2.
Matsumoto T, Ishikawa H, Tateda K, Yaeshima T, Ishibashi N, Yamaguchi K . Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice. J Appl Microbiol. 2007; 104(3):672-80. DOI: 10.1111/j.1365-2672.2007.03593.x. View

3.
Schultz M . Symbiotics as a preventive measure against ventilator-associated pneumonia. Crit Care Med. 2010; 38(6):1506-7. DOI: 10.1097/CCM.0b013e3181d8c473. View

4.
Kirkby N, Zaiss A, Wright W, Jiao J, Chan M, Warner T . Differential COX-2 induction by viral and bacterial PAMPs: Consequences for cytokine and interferon responses and implications for anti-viral COX-2 directed therapies. Biochem Biophys Res Commun. 2013; 438(2):249-56. PMC: 3759847. DOI: 10.1016/j.bbrc.2013.07.006. View

5.
Xu F, Xu Z, Zhang R, Wu Z, Lim J, Koga T . Nontypeable Haemophilus influenzae induces COX-2 and PGE2 expression in lung epithelial cells via activation of p38 MAPK and NF-kappa B. Respir Res. 2008; 9:16. PMC: 2270828. DOI: 10.1186/1465-9921-9-16. View